In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Koselugo, as a small molecule blocker of the MEK signaling pathway, has a core e···【more】
Release date:2024-08-21Recommended:543
Koselugo is a small molecule inhibitor targeting the MEK signaling pathway, main···【more】
Release date:2024-08-21Recommended:527
Koselugo is a small molecule inhibitor targeting MEK, which plays the role of a ···【more】
Release date:2024-08-21Recommended:475
Koselugo is a small molecule MEK inhibitor and a repressor of mitogen activation···【more】
Release date:2024-08-21Recommended:475
Koselugois a small molecule MEK inhibitor (mitogen activation inhibitor), and it···【more】
Release date:2024-08-21Recommended:475
The therapeutic effect of Mitotane is aimed at adrenal cortical carcinoma, hyper···【more】
Release date:2024-08-20Recommended:482
Anamorelin is the first drug specifically for the treatment of cachexia launched···【more】
Release date:2024-08-20Recommended:430
In 2021, Japan launched Anamorelin, the world's first drug specifically for ···【more】
Release date:2024-08-20Recommended:549
Anamorelin is the world's first drug specifically for the treatment of cache···【more】
Release date:2024-08-20Recommended:570
In 2021, Ono Pharmaceutical of Japan launched Anamorelin, a ghrelin receptor ago···【more】
Release date:2024-08-20Recommended:609
Anamorelin is the first cachexia treatment drug launched in Japan in 2021, which···【more】
Release date:2024-08-20Recommended:579
Launched in Japan in 2021, anamoline is the world's first drug specifically ···【more】
Release date:2024-08-20Recommended:547